HD-OPM Archive
Topics › Fasting & meal timing

6-month intermittent fasting RCT: ~8% weight loss, non-HDL down 11%, TG down 23%

Louis Nervegna · Jan 29, 2026 · ♥ 8 reactions · 3 comments · original Facebook post
Fasting & meal timingLDL, ApoB & lipid panel
AI summary & key facts

Louis shares Luigi Fontana's Nature Communications secondary-outcomes paper on 6 months of intermittent fasting in middle-aged adults with overweight. Lipids and body fat improved, but glucose, insulin resistance, blood pressure, inflammation and carotid IMT did not change.

Recently published randomized trial demonstrating significant benefits of intermittent fasting in humans:

Cardiometabolic and molecular adaptations to 6-month intermittent fasting in middle-aged men and women with overweight: secondary outcomes of a randomized controlled trial - November 2025 - Nature Communications

#fastingHD

Research cited

Intermittent fasting is everywhere—but how does it actually work in humans?

We’re excited to share our new paper in Nature Communications. We followed middle-aged men and women with overweight for 6 months of intermittent fasting and went deep, from cardiometabolic outcomes to colon tissue multi-omics.

What we found 👇
✅ Meaningful weight and fat loss: ~8% body weight reduction and ~16% body fat reduction (DXA)
✅ Selective lipid improvements: significant reductions in atherogenic lipids, including non-HDL cholesterol ↓ ~11% and triglycerides ↓ ~23% (LDL-C also decreased significantly)
❌ Most other cardiometabolic risk factors did not change: no major effects on glucose, insulin resistance, blood pressure, inflammation, or carotid IMT

This highlights an important point: intermittent fasting is not a substitute for a healthy lifestyle. In this trial, participants largely maintained a typical “Western” dietary pattern on non-fasting days, and improvements beyond lipids were limited.

The surprise?
🧬 IF was associated with clear shifts in gut-derived molecular pathways, including:

Key takeaway (and caution):
The real opportunity may be using IF as a tool to potentiate the benefits of higher diet quality + physical activity + sustainable lifestyle changes—not as a standalone fix.

Proud of my team and grateful to everyone who made this work possible.

📖 Full paper:

Paper · Nat Commun · 2025Cardiometabolic and molecular adaptations to 6-month intermittent fasting in middle-aged men and women with overweight: secondary outcomes of a randomized controlled trialdoi.org

#FastingScience #Metabolism #CardiometabolicHealth #GutHealth #PrecisionNutrition #ClinicalTrials #NatureCommunications

No photo description available.No photo description available.No photo description available.No photo description available.No photo description available.
← newer: People who survive cancer have lower Alzheimer's risk; mouseolder: Video fact-checks saturated fat and heart disease misinforma →